YCR102W-A Antibody

What is YCR102W-A antibody and what organism does it target?

YCR102W-A antibody is a rabbit polyclonal antibody specifically developed to target the putative uncharacterized protein YCR102W-A in Saccharomyces cerevisiae (strain 204508/S288c), commonly known as baker's yeast. This antibody has been developed through antigen-affinity purification methods and belongs to the IgG isotype. The antibody is primarily used for detecting and analyzing the YCR102W-A protein in yeast cell extracts through various immunological techniques.

What are the validated applications for YCR102W-A antibody?

Based on comprehensive validation studies, YCR102W-A antibody has been specifically validated for two primary applications:

• Enzyme-Linked Immunosorbent Assay (ELISA) - For quantitative detection of YCR102W-A protein in solution

• Western Blot (WB) - For detection of denatured YCR102W-A protein in cell lysates

These applications have been validated to ensure proper identification of the target antigen in Saccharomyces cerevisiae samples. Other potential applications would require independent validation before use in critical research.

How should YCR102W-A protein samples be prepared from yeast cultures?

Proper preparation of yeast samples is critical for successful detection of YCR102W-A protein. The recommended protocol includes:

• Inoculate 4ml of DOB-Trp media with a single yeast colony and incubate with shaking for 3-4 days at 30°C

• Transfer 1.0ml of culture to microcentrifuge tubes and pellet cells with a quick spin

• Aspirate supernatant and resuspend cells in 100μl of loading buffer

• Add 25μl of glass beads to a microcentrifuge tube

• Transfer resuspended cells to the tube with beads and vortex for 1-2 minutes to disrupt cell walls

• Boil the cell/bead mixture for 10 minutes to denature proteins

• Centrifuge briefly to separate cell debris from protein extract

• Use the supernatant containing the solubilized proteins for downstream applications

This mechanical disruption method is particularly effective for yeast cells which have rigid cell walls that resist standard mammalian cell lysis methods.

How should experiments using YCR102W-A antibody be designed to ensure valid results?

When designing experiments with YCR102W-A antibody, researchers should follow these key principles:

• Define clear variables: Establish your independent variable (such as growth conditions, genetic modifications, or treatments affecting YCR102W-A expression) and dependent variable (YCR102W-A protein detection levels)

• Formulate specific hypotheses: Create testable predictions about YCR102W-A protein expression or function

• Include proper controls: Always incorporate both positive controls (known YCR102W-A-expressing samples) and negative controls (samples without YCR102W-A expression)

• Use appropriate experimental treatments: Design treatments that specifically manipulate YCR102W-A expression or function

• Plan appropriate measurement techniques: Select detection methods with suitable sensitivity for the expected protein abundance

Statistical considerations should be incorporated from the beginning, including determining appropriate sample sizes and planning replicate experiments to ensure reproducibility and significance of findings.

What controls are essential when working with an antibody targeting an uncharacterized protein like YCR102W-A?

When working with antibodies against uncharacterized proteins like YCR102W-A, implementing rigorous controls is crucial:

• Specificity controls:

  • Wild-type vs. YCR102W-A knockout yeast strains

  • Pre-immune serum controls to assess background binding

  • Competitive inhibition with the immunizing peptide

• Technical controls:

  • Loading controls (such as actin or GAPDH) to normalize protein loading

  • Secondary antibody-only controls to detect non-specific binding

  • Cross-reactivity testing with related yeast proteins

• Expression validation:

  • Correlation of protein detection with mRNA expression data

  • Tagged protein expression to confirm antibody detection corresponds to actual protein presence

These controls are particularly important for uncharacterized proteins where standard reference data may be limited.

What is the optimal Western Blot protocol for detecting YCR102W-A protein in yeast samples?

For optimal Western Blot detection of YCR102W-A in yeast samples, follow this detailed protocol:

• Sample preparation:

  • Prepare yeast lysates as described in section 1.3

  • Load 25μl of protein extract per well

• Gel electrophoresis:

  • Use a 5% stacking/8% resolving acrylamide gel

  • Include 7μl of protein standard markers

  • Run at 100V until loading dye reaches bottom edge

• Protein transfer:

  • Assemble transfer sandwich: porous pad → white paper → gel → transfer paper → white paper → porous pad

  • Transfer at 30V overnight

  • Trim transfer paper to gel size

• Blocking and washing:

  • Block with 5% milk solution for 1 hour (55 RPM shaking)

  • Wash with TBST: 30 minutes, then 1 hour (55 RPM)

• Antibody incubation:

  • Primary antibody (YCR102W-A): Incubate for 1 hour (55 RPM)

  • Wash 4 times with TBST (2× 15 minutes, 2× 10 minutes)

  • Secondary antibody: Incubate for 1 hour (55 RPM)

  • Wash 4 times with TBST as above

• Detection:

  • Apply 1.5ml of each ECL reagent for 1 minute

  • Drain excess reagent, wrap in plastic

  • Expose to film for approximately 3 minutes and develop

Optimization note: If signal is weak, consider longer primary antibody incubation (overnight at 4°C) or increased antibody concentration.

What troubleshooting approaches should be used when Western Blot detection of YCR102W-A yields unexpected results?

When encountering issues with YCR102W-A detection in Western Blots, consider these systematic troubleshooting approaches:

For uncharacterized proteins like YCR102W-A, initial Western Blot optimization might require testing multiple antibody concentrations and incubation times to establish optimal detection parameters.

How can YCR102W-A antibody be used to study protein-protein interactions in yeast?

YCR102W-A antibody can be leveraged for investigating protein-protein interactions through several advanced methodologies:

• Co-immunoprecipitation (Co-IP):

  • Use YCR102W-A antibody conjugated to agarose/magnetic beads

  • Incubate with native yeast lysates to capture protein complexes

  • Elute and analyze interacting partners by mass spectrometry

• Proximity Ligation Assay (PLA):

  • Combine YCR102W-A antibody with antibodies against suspected interaction partners

  • Use species-specific secondary antibodies with oligonucleotide probes

  • Analyze fluorescent amplification signals indicating protein proximity (<40nm)

• Immunofluorescence co-localization:

  • Use YCR102W-A antibody in combination with organelle markers

  • Establish subcellular localization patterns through confocal microscopy

  • Quantify co-localization coefficients to identify potential interaction sites

When working with uncharacterized proteins like YCR102W-A, these interaction studies can provide critical functional insights that complement genetic and biochemical characterization approaches.

What approaches can be used to validate YCR102W-A antibody specificity for critical research applications?

For rigorous validation of YCR102W-A antibody specificity, researchers should implement a multi-faceted approach:

• Genetic validation:

  • Compare antibody reactivity in wild-type vs. YCR102W-A deletion strains

  • Test detection in strains with YCR102W-A gene overexpression

  • Assess cross-reactivity with closely related yeast gene products

• Biochemical validation:

  • Perform peptide competition assays with immunizing peptide

  • Analyze multiple yeast strains with varied genetic backgrounds

  • Correlate Western Blot detection with mRNA expression levels

• Advanced validation methods:

  • Epitope mapping to confirm binding to specific protein regions

  • Mass spectrometry analysis of immunoprecipitated proteins

  • Correlation with tagged YCR102W-A protein detection

• Cross-platform validation:

  • Compare antibody detection with orthogonal methods (e.g., mRNA analysis)

  • Test functionality across multiple applications (Western Blot, ELISA, IP)

This comprehensive validation is particularly critical for antibodies targeting uncharacterized proteins where standard reference data may be limited.

What is the optimal ELISA protocol for YCR102W-A protein quantification?

For accurate quantification of YCR102W-A protein using ELISA, follow this optimized protocol:

• Plate preparation:

  • Coat 96-well plates with capture antibody (anti-rabbit IgG) at 2μg/ml in carbonate buffer (pH 9.6)

  • Incubate overnight at 4°C

  • Wash 3× with PBS-T (PBS + 0.05% Tween-20)

• Blocking:

  • Block with 5% BSA in PBS for 2 hours at room temperature

  • Wash 3× with PBS-T

• Sample application:

  • Prepare yeast lysates (using the protocol in section 1.3)

  • Prepare serial dilutions of samples in sample buffer

  • Apply 100μl per well

  • Incubate for 2 hours at room temperature

  • Wash 4× with PBS-T

• Detection antibody:

  • Apply YCR102W-A antibody at optimal dilution

  • Incubate for 2 hours at room temperature

  • Wash 4× with PBS-T

• Secondary antibody:

  • Apply HRP-conjugated anti-rabbit IgG

  • Incubate for 1 hour at room temperature

  • Wash 5× with PBS-T

• Development and quantification:

  • Add TMB substrate and monitor color development

  • Stop reaction with 2N H₂SO₄

  • Read absorbance at 450nm with 570nm reference

  • Calculate concentration using standard curve

For uncharacterized proteins like YCR102W-A, establishing a reliable standard curve may require additional validation steps.

How can researchers assess cross-reactivity of YCR102W-A antibody with other yeast proteins in ELISA?

To assess potential cross-reactivity of YCR102W-A antibody in ELISA applications:

• Pre-adsorption testing:

  • Pre-incubate antibody with lysates from YCR102W-A knockout yeast

  • Compare ELISA signals between pre-adsorbed and non-adsorbed antibody

  • Significant signal reduction after pre-adsorption indicates specificity

• Competitive inhibition assay:

  • Perform ELISA with increasing concentrations of purified YCR102W-A protein or immunizing peptide

  • Plot inhibition curve to assess binding specificity

  • True specific binding will show dose-dependent inhibition

• Cross-species testing:

  • Test reactivity against lysates from related yeast species with homologous proteins

  • Compare signal intensities to assess cross-reactivity potential

  • Sequence analysis of homologs can predict potential cross-reactivity

• Negative control screening:

  • Test against a panel of purified yeast proteins with similar properties

  • Include structurally similar proteins based on bioinformatic prediction

  • Quantify any non-specific binding signals

These validation steps help ensure that quantitative measurements accurately reflect YCR102W-A protein levels rather than non-specific interactions.

How can researchers design knockdown/knockout experiments to study YCR102W-A protein function?

To investigate the functional role of the uncharacterized YCR102W-A protein, researchers can implement these genetic manipulation approaches:

• CRISPR-Cas9 knockout strategy:

  • Design guide RNAs targeting YCR102W-A gene

  • Prepare repair templates with selection markers

  • Transform yeast with CRISPR components

  • Screen transformants for successful gene deletion

  • Validate knockouts by PCR and Western Blot using YCR102W-A antibody

• Conditional expression systems:

  • Replace endogenous YCR102W-A promoter with regulatable promoter (e.g., GAL1)

  • Allow controlled expression/repression of the protein

  • Monitor phenotypic changes using YCR102W-A antibody to confirm protein levels

• RNA interference approaches:

  • Design shRNA constructs targeting YCR102W-A mRNA

  • Express in appropriate yeast systems

  • Validate knockdown efficiency using YCR102W-A antibody

  • Correlate knockdown levels with observed phenotypes

• Experimental design considerations:

  • Include complementation tests to confirm phenotype specificity

  • Perform time-course analyses of protein depletion

  • Correlate protein levels with phenotypic changes

After manipulation, comprehensive phenotypic analysis should include growth rates, morphology, stress responses, and molecular pathway analyses to identify the protein's functional role.

What approaches can researchers use to identify potential binding partners or substrates of YCR102W-A protein?

For identifying interaction partners of the uncharacterized YCR102W-A protein, researchers should consider these complementary approaches:

• Immunoprecipitation-Mass Spectrometry (IP-MS):

  • Use YCR102W-A antibody for immunoprecipitation from native yeast lysates

  • Analyze co-precipitated proteins by liquid chromatography-mass spectrometry

  • Compare results to control IPs to identify specific interactions

  • Validate top candidates with reciprocal IP experiments

• Yeast Two-Hybrid Screening:

  • Clone YCR102W-A as bait fusion protein

  • Screen against yeast genomic or cDNA libraries

  • Validate primary hits with secondary assays

  • Confirm in vivo relevance with co-IP using YCR102W-A antibody

• Proximity-dependent Labeling:

  • Generate YCR102W-A fusion with BioID or APEX2

  • Allow in vivo biotinylation of proximal proteins

  • Purify biotinylated proteins and identify by mass spectrometry

  • Validate spatial proximity with microscopy using YCR102W-A antibody

• Cross-linking Mass Spectrometry:

  • Treat yeast cells with protein cross-linkers

  • Immunoprecipitate YCR102W-A complexes using the antibody

  • Identify cross-linked peptides by specialized MS approaches

  • Map interaction interfaces at amino acid resolution

The combination of multiple complementary approaches provides higher confidence in identified interaction partners, particularly important for previously uncharacterized proteins.

How can researchers adapt YCR102W-A antibody for immunofluorescence microscopy in yeast cells?

Adapting YCR102W-A antibody for successful immunofluorescence microscopy in yeast requires specialized protocols to overcome the challenging yeast cell wall:

• Cell preparation:

  • Grow yeast to mid-log phase

  • Fix with 3.7% formaldehyde for 30 minutes

  • Prepare spheroplasts using zymolyase (100T, 1mg/ml) for 20-30 minutes at 30°C

  • Monitor spheroplasting microscopically to prevent over-digestion

• Permeabilization and blocking:

  • Permeabilize with 0.1% Triton X-100 for 10 minutes

  • Block with 1% BSA, 0.1% Tween-20 in PBS for 1 hour

  • Include 5% normal goat serum to reduce background

• Antibody incubation:

  • Apply YCR102W-A primary antibody (1:100-1:500 dilution range)

  • Incubate overnight at 4°C in humid chamber

  • Wash 5× with PBS-T

  • Apply fluorophore-conjugated anti-rabbit secondary antibody

  • Incubate 2 hours at room temperature

  • Wash 5× with PBS-T

• Mounting and imaging:

  • Mount with anti-fade medium containing DAPI

  • Use confocal microscopy with appropriate filter sets

  • Collect Z-stack images to capture complete spheroplast volume

Negative controls (primary antibody omission, unrelated primary antibody) are essential for distinguishing specific from non-specific signals in yeast immunofluorescence.

What considerations are important when adapting YCR102W-A antibody for chromatin immunoprecipitation (ChIP) experiments?

For adapting YCR102W-A antibody to chromatin immunoprecipitation to study potential DNA interactions:

• Chromatin preparation:

  • Crosslink yeast cells with 1% formaldehyde for 15 minutes

  • Quench with 125mM glycine

  • Lyse cells using glass bead disruption in lysis buffer containing protease inhibitors

  • Sonicate chromatin to 200-500bp fragments

  • Verify fragmentation by agarose gel electrophoresis

• Antibody optimization:

  • Test multiple concentrations of YCR102W-A antibody (2-10μg per reaction)

  • Include IgG control and input samples

  • Validate antibody specificity in IP conditions prior to ChIP

  • Consider using protein A/G magnetic beads for improved recovery

• ChIP protocol adaptation:

  • Pre-clear chromatin with protein A/G beads

  • Incubate cleared chromatin with YCR102W-A antibody overnight at 4°C

  • Capture antibody-bound chromatin with protein A/G beads

  • Wash stringently to remove non-specific DNA

  • Elute and reverse crosslinks

  • Purify DNA for qPCR or sequencing

• Validation approaches:

  • Use YCR102W-A knockout strain as negative control

  • Perform spike-in normalization for quantitative comparisons

  • Validate ChIP-qPCR findings with orthogonal methods

Since YCR102W-A is uncharacterized, initial ChIP experiments should include broad approaches like ChIP-seq to identify potential genome-wide binding patterns before focusing on specific loci.

How does antibody-based detection of YCR102W-A compare with genetic tagging approaches?

When deciding between antibody-based detection and genetic tagging for studying YCR102W-A, researchers should consider these comparative factors:

For comprehensive characterization of uncharacterized proteins like YCR102W-A, combining both approaches provides complementary data: antibody detection confirms native protein behavior while tagging enables dynamic studies.

What mass spectrometry approaches can complement antibody-based detection of YCR102W-A?

Mass spectrometry provides powerful complementary approaches to antibody-based detection of YCR102W-A:

• Protein identification and validation:

  • Immunoprecipitate YCR102W-A using the antibody

  • Analyze by LC-MS/MS to confirm protein identity

  • Validate antibody specificity through peptide sequence identification

  • Map detected peptides to protein sequence for coverage analysis

• Post-translational modification mapping:

  • Enrich YCR102W-A by immunoprecipitation

  • Analyze by specialized MS techniques for PTMs

  • Identify phosphorylation, ubiquitination, or other modifications

  • Quantify modification stoichiometry under different conditions

• Absolute protein quantification:

  • Develop selected reaction monitoring (SRM) or parallel reaction monitoring (PRM) assays

  • Use isotopically labeled peptide standards

  • Quantify YCR102W-A absolute abundance in different conditions

  • Compare with antibody-based quantification methods

• Protein-protein interaction analysis:

  • Combine antibody-based IP with MS analysis

  • Identify co-immunoprecipitated proteins

  • Validate interactions using reciprocal IP approaches

  • Map interaction changes under different cellular conditions

This integrated approach leverages the enrichment capability of the YCR102W-A antibody with the identification and characterization power of mass spectrometry, particularly valuable for uncharacterized proteins.

What are the most common issues when working with antibodies against uncharacterized proteins like YCR102W-A?

When working with antibodies against uncharacterized proteins like YCR102W-A, researchers commonly encounter these challenges:

• Validation challenges:

  • Limited reference standards for comparison

  • Uncertain protein expression levels or patterns

  • Difficulty confirming antibody specificity without characterized knockout models

• Detection issues:

  • Unknown optimal detection conditions (denaturing vs. native)

  • Potential post-translational modifications affecting epitope recognition

  • Unpredictable cross-reactivity with related proteins

• Experimental design problems:

  • Difficulty designing appropriate controls

  • Uncertain subcellular localization affecting extraction efficiency

  • Unknown stability characteristics affecting experimental handling

• Data interpretation complications:

  • Limited functional context for observed expression patterns

  • Difficulty distinguishing specific from non-specific signals

  • Challenges correlating protein detection with phenotypic observations

Addressing these challenges requires systematic optimization approaches and corroboration of findings with complementary techniques.

How can researchers assess batch-to-batch variability of YCR102W-A antibody for longitudinal studies?

To ensure consistent results in longitudinal studies using YCR102W-A antibody, implement these quality control measures:

• Reference standard preparation:

  • Create large batches of control yeast lysates (wild-type and YCR102W-A overexpression)

  • Aliquot and store at -80°C for long-term use

  • Use these standards to calibrate each new antibody batch

• Validation protocol:

  • Develop a standardized validation assay panel

  • Test each new batch for:

    • Titer by ELISA

    • Detection limit by Western Blot

    • Signal-to-noise ratio

    • Cross-reactivity profile

• Quantitative benchmarking:

  • Establish quantitative metrics for acceptable performance

  • Document lot-to-lot variation

  • Create control charts to monitor performance trends

  • Set acceptance criteria for each application

• Mitigation strategies:

  • Purchase larger lots when consistent performance is observed

  • Consider monoclonal alternatives for critical applications

  • Validate multiple antibodies targeting different epitopes

  • Implement bridging studies when changing lots

For longitudinal studies spanning years, maintaining reference standards and detailed documentation of antibody performance characteristics is essential for distinguishing biological changes from technical variability.

How can YCR102W-A antibody be used in large-scale yeast functional genomics studies?

YCR102W-A antibody can be integrated into large-scale functional genomics approaches through these methodological strategies:

• Systematic genetic interaction mapping:

  • Screen YCR102W-A expression across yeast deletion/overexpression libraries

  • Use the antibody to quantify protein levels by automated Western Blot

  • Correlate genetic perturbations with YCR102W-A protein abundance

  • Identify genes functionally connected to YCR102W-A regulation

• Chemical-genetic profiling:

  • Expose yeast to chemical/drug libraries

  • Measure YCR102W-A protein response by high-throughput ELISA

  • Identify compounds affecting YCR102W-A expression/stability

  • Map chemical-genetic interaction networks

• Integration with other -omics approaches:

  • Combine with transcriptomics data to correlate mRNA/protein levels

  • Integrate with metabolomics to link YCR102W-A to metabolic pathways

  • Correlate with phosphoproteomics to identify regulatory mechanisms

  • Develop computational models incorporating multi-omics data

• High-content screening applications:

  • Use immunofluorescence with YCR102W-A antibody

  • Implement automated microscopy for phenotypic analysis

  • Quantify protein localization, abundance, and distribution

  • Identify conditions affecting protein behavior

These approaches position YCR102W-A antibody as a valuable tool within the broader context of systems biology investigations, particularly for understanding the function of this uncharacterized protein.

What emerging technologies can enhance the research value of YCR102W-A antibody?

Several emerging technologies can significantly enhance the research applications of YCR102W-A antibody:

• Microfluidic immunoassays:

  • Develop miniaturized assay platforms for YCR102W-A detection

  • Enable real-time monitoring with minimal sample consumption

  • Integrate with single-cell analysis platforms

  • Allow high-throughput screening with reduced reagent costs

• Proximity labeling applications:

  • Conjugate YCR102W-A antibody with proximity labeling enzymes (APEX2, TurboID)

  • Map protein microenvironments in intact yeast cells

  • Identify transient interactors through temporal control of labeling

  • Combine with mass spectrometry for comprehensive interactome mapping

• Super-resolution microscopy adaptations:

  • Optimize YCR102W-A antibody for STORM, PALM, or STED microscopy

  • Achieve nanoscale resolution of protein localization

  • Investigate co-localization with unprecedented precision

  • Correlate spatial organization with functional outputs

• Single-molecule detection approaches:

  • Adapt YCR102W-A antibody for single-molecule pull-down (SiMPull)

  • Analyze stoichiometry of protein complexes

  • Measure binding kinetics at the single-molecule level

  • Investigate heterogeneity in protein complex composition